HORIZONH2020
I3S - Instituto de Investigacao e Inovacao Em Saude da Universidade do Porto
- Country
- PTPortugal
- Defence projects
- 0
- Projects, all programmes
- 35
- As coordinator
- 10
- EU contribution (CORDIS)
- EUR 21,097,686
- Active
- 2021 to 2026
Projects
35 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| URC-HypoxiaUnlocking the Redox Code: Mapping the Molecular Mechanisms of Hypoxia Tolerance | HORIZON | 2026 | Coordinator | EUR 207,183 |
| Target-MelaneXTargeted therapy to block melanoma progression through peptide phage-display profiling of melanoma cells and derived extracellular vesicles | HORIZON | 2026 | Coordinator | EUR 207,183 |
| TB-SPECTRUMA step forward for unraveling the immune mechanisms and tools for tuberculosis spectrum management | HORIZON | 2026 | Participant | Not stated |
| MEDiCSAnticancer approach based on the Metabolic Disruption of Cancer Stem Cells with high effectivity across a wide range of solid tumours | HORIZON | 2025 | Participant | EUR 335,750 |
| FOCUS-4RFostering Outermost regions Capabilities in Research and Innovation and Upgrading Skills complying with 4R principles | HORIZON | 2025 | Participant | Not stated |
| KAREVOHow dividing cells adapt to karyotypic evolution | HORIZON | 2025 | Coordinator | EUR 2,955,225 |
| GLYCOCALYXSelf-organisation and barrier functions of the mammalian glycocalyx Training glycoscientists across disciplines and borders to stimulate new approaches, understanding and biomedical applications | HORIZON | 2025 | Participant | Not stated |
| PREDI-LYNCHValidated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome | HORIZON | 2025 | Participant | EUR 380,323 |
| BREATHBoosting future REsearchers in biomaterials for Advanced healTH solutions | HORIZON | 2025 | Associated partner | EUR 0 |
| Natural TracesNatural Traces in forensic investigations - how the analysis of non-human evidence can solve crime | HORIZON | 2024 | Associated partner | EUR 0 |
| BonePainIIIIdentifying mechanisms and novel treatments of bone pain – closing the gap to the clinic. | HORIZON | 2024 | Participant | EUR 243,403 |
| EU-EMBRACESEmpowering Minds: Boosting Research in Citizen Engagement and Schools | HORIZON | 2024 | Participant | EUR 73,981 |
| IMPULSEIMProving User experience, Long-term sustainability and Services of EU-OPENSCREEN | HORIZON | 2024 | Participant | EUR 61,304 |
| MENTORINGAddressing malnutrition and metabolic health in non-communicable diseases through precision Nutrition: impact in quality of life and prognosis of lung cancer patients. | HORIZON | 2024 | Participant | EUR 404,183 |
| AI4LUNGSAI-BASED PERSONALISED CARE FOR RESPIRATORY DISEASE USING MULTI-MODAL DATA IN PATIENT STRATIFICATION | HORIZON | 2024 | Participant | EUR 374,706 |
| D-PhosMateDynamic Peptide-Phosphate-based Hydrogels for Modelling Diseases and Therapeutic Interventions | HORIZON | 2024 | Coordinator | EUR 156,779 |
| PREVENTABLECANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE | HORIZON | 2023 | Coordinator | EUR 2,065,602 |
| GlyCanDrugA training network on the design of precision therapeutics that target key glycan motifs implicated in cancer | HORIZON | 2023 | Participant | EUR 243,403 |
| GlycanSwitchGlycans as Master Switches of B Cell Activity in Autoimmunity | HORIZON | 2023 | Participant | EUR 2,500,000 |
| GlycanTriggerGLYCANS AS MASTER TRIGGERS OF HEALTH TO INTESTINAL INFLAMMATION TRANSITION | HORIZON | 2023 | Coordinator | EUR 3,478,500 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.